RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Interpace Biosciences - Stock

Interpace Biosciences Net Income 2024

Interpace Biosciences Net Income

802,000 USD

Ticker

IDXG

ISIN

US46062X3035

WKN

A2PYCU

In 2024, Interpace Biosciences's profit amounted to 802,000 USD, a -103.65% increase from the -22 M USD profit recorded in the previous year.

The Interpace Biosciences Net Income history

YEARNET INCOME (undefined USD)
20230.8
2022-22
2021-14.9
2020-29.5
2019-27.2
2018-12.7
2017-12.2
2016-8.3
2015-11.4
2014-16.1
2013-4.6
2012-25.5
2011-11.9
2010-6.8
2009-33.6
2008-34.5
2007-10
200611.8
2005-19.5
200421.1

Interpace Biosciences Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Interpace Biosciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Interpace Biosciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Interpace Biosciences’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Interpace Biosciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Interpace Biosciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Interpace Biosciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Interpace Biosciences’s growth potential.

Interpace Biosciences Revenue, EBIT and net profit per share

DateInterpace Biosciences RevenueInterpace Biosciences EBITInterpace Biosciences Net Income
202340.21 M undefined2.8 M undefined802,000 undefined
202231.8 M undefined-3.6 M undefined-22 M undefined
202133.1 M undefined-5.4 M undefined-14.9 M undefined
202032.4 M undefined-26.1 M undefined-29.5 M undefined
201924.2 M undefined-23.9 M undefined-27.2 M undefined
201821.9 M undefined-12.6 M undefined-12.7 M undefined
201715.9 M undefined-6.3 M undefined-12.2 M undefined
201613.1 M undefined-3 M undefined-8.3 M undefined
20159.4 M undefined-22.9 M undefined-11.4 M undefined
20141.5 M undefined-15.7 M undefined-16.1 M undefined
2013146.5 M undefined-1.4 M undefined-4.6 M undefined
2012126.9 M undefined-1 M undefined-25.5 M undefined
2011157.3 M undefined-1.8 M undefined-11.9 M undefined
2010134.6 M undefined-4.9 M undefined-6.8 M undefined
200980.4 M undefined-10.4 M undefined-33.6 M undefined
2008105.2 M undefined-32.4 M undefined-34.5 M undefined
2007117.1 M undefined-12.9 M undefined-10 M undefined
2006239.2 M undefined5.1 M undefined11.8 M undefined
2005305.2 M undefined-2.8 M undefined-19.5 M undefined
2004345.8 M undefined37 M undefined21.1 M undefined

Interpace Biosciences stock margins

The Interpace Biosciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Interpace Biosciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Interpace Biosciences.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Interpace Biosciences's sales revenue. A higher gross margin percentage indicates that the Interpace Biosciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Interpace Biosciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Interpace Biosciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Interpace Biosciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Interpace Biosciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Interpace Biosciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Interpace Biosciences Margin History

Interpace Biosciences Gross marginInterpace Biosciences Profit marginInterpace Biosciences EBIT marginInterpace Biosciences Profit margin
202359.44 %6.97 %1.99 %
202257.23 %-11.32 %-69.18 %
202156.8 %-16.31 %-45.02 %
202033.02 %-80.56 %-91.05 %
201934.3 %-98.76 %-112.4 %
201853.42 %-57.53 %-57.99 %
201753.46 %-39.62 %-76.73 %
201648.85 %-22.9 %-63.36 %
201526.6 %-243.62 %-121.28 %
201413.33 %-1,046.67 %-1,073.33 %
201316.04 %-0.96 %-3.14 %
201221.2 %-0.79 %-20.09 %
201120.66 %-1.14 %-7.57 %
201019.76 %-3.64 %-5.05 %
200930.47 %-12.94 %-41.79 %
20082 %-30.8 %-32.79 %
200726.99 %-11.02 %-8.54 %
200623.33 %2.13 %4.93 %
200517.17 %-0.92 %-6.39 %
200426.78 %10.7 %6.1 %

Interpace Biosciences Aktienanalyse

What does Interpace Biosciences do?

Interpace Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Interpace Biosciences's Profit Margins

The profit margins of Interpace Biosciences represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Interpace Biosciences's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Interpace Biosciences's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Interpace Biosciences's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Interpace Biosciences’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Interpace Biosciences Stock

How much profit has Interpace Biosciences made this year?

Interpace Biosciences has made 802,000 USD this year.

How has the profit developed compared to last year?

The profit has increased by -103.65% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Interpace Biosciences publish its earnings?

Interpace Biosciences publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Interpace Biosciences?

The profits of Interpace Biosciences are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Interpace Biosciences?

You can learn more about the earnings of Interpace Biosciences by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Interpace Biosciences pay?

Over the past 12 months, Interpace Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Interpace Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Interpace Biosciences?

The current dividend yield of Interpace Biosciences is .

When does Interpace Biosciences pay dividends?

Interpace Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Interpace Biosciences?

Interpace Biosciences paid dividends every year for the past 0 years.

What is the dividend of Interpace Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Interpace Biosciences located?

Interpace Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Interpace Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Interpace Biosciences from 7/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/3/2024.

When did Interpace Biosciences pay the last dividend?

The last dividend was paid out on 7/3/2024.

What was the dividend of Interpace Biosciences in the year 2023?

In the year 2023, Interpace Biosciences distributed 0 USD as dividends.

In which currency does Interpace Biosciences pay out the dividend?

The dividends of Interpace Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Interpace Biosciences stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Interpace Biosciences

Our stock analysis for Interpace Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Interpace Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.